AbbVie Inc.
ANTI-CD40 ANTIBODY DRUG CONJUGATES

Last updated:

Abstract:

Provided herein are anti-CD40 antibody drug conjugates comprising a radical of Formula (I), wherein R.sup.1, R.sup.2, and R.sup.3 are as defined herein. Further provided are anti-CD40 antibody drug conjugates of Formula (II), wherein Z, R, AA1, AA2, AA3, m, p, q, n, w, R.sup.1, R.sup.2, and R.sup.3 are as defined herein. Further provided are pharmaceutical compositions and kits thereof, and methods of using same. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

29 Nov 2018

Issue date:

25 Aug 2022